Brief: Simcere Pharmaceutical Announces Spin-Off & Separate Listing Of Simcere Zaiming Pharmaceutical
09/01/2026 17:50
Jan 9 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK: PROPOSED SPIN-OFF AND SEPARATE LISTING OF SIMCERE ZAIMING PHARMACEUTICAL LISTING OF SIMCERE ZAIMING PHARMACEUTICAL ON MAIN BOARD OF STOCK EXCHANGE OF HONG KONG UPON COMPLETION, CO EXPECTED TO HAVE INTEREST OF OVER 50% IN SIMCERE ZAIMING Further company coverage: 2096.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660